GHAPP Regional - Dallas, TX

Agenda

5:00-5:30 PM- Registration and Reception

5:30-6:00 PM- First and Only FDA-Approved Eosinophilic Esophagitis (EoE) Treatment - Provided by: Sanofi/Regeneron

6:00-6:30 PM- Dinner and Exhibits

6:30-8:00 PM- Hot Topics in Liver and GI

8:00-8:15 PM- Closing Remarks & Adjourn

Educational Objectives

After completing this activity, participants should be better able to:​

• Describe current screening, diagnosis, and management options for patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders
• Apply optimal treatment strategies for patients with CLD and GI disorders
• Compare and contrast currently available treatment modalities for CLD and GI disorders

Target Audience

This activity has been designed to meet the educational needs of APP’s involved in the care of patients with CLD and GI Disorders.​​

Industry-employed healthcare providers are not permitted to register unless sponsoring the meeting. Registrants must be active advanced practice providers in a community or academic setting.

If interested in sponsoring this event, please contact Robert Taglienti at rtaglienti@taggrp.com